The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for L Beigelman


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
3
Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.EBI
University of Montpellier
10
Synthesis and Anti-HCV Activity of Sugar-Modified Guanosine Analogues: Discovery of EBI
Janssen Biopharma
13
Synthesis and Anti-HCV Activities of 4'-Fluoro-2'-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4'-Fluoro-2'- C-methyluridine 5'-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection.EBI
Janssen Biopharma
1
Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3/4A protease.EBI
Array Biopharma
13
Bipyrazole derivatives as JAK inhibitorsBDB
Incyte
137
Compounds and methods useful in the treatment of a PRMT5-mediated disorderBDB
Argonaut Therapeutics
19
Sphingosine analogs and use thereof against bacterial lung infectionsBDB
Yeda Research and Development
25
MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORSBDB
Merck Sharp &Amp
14
Azaspiro[4.5]decane derivatives and use thereofBDB
Purdue Pharma
15
Calcium channel inhibitorsBDB
Cavion
35
Factor XIIa inhibitorsBDB
Merck Sharp & Dohme
4
Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulatorsBDB
Arena Pharmaceuticals